Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
Li Y, Liang Z, Qin L, Wang M, Wang X, Zhang H, Liu Y, Li Y, Jia Z, Liu L, Zhang H, Luo J, Dong S, Guo J, Zhu H, Li S, Zheng H, Liu L, Wu Y, Zhong Y, Qiu M, Han Y, Stone GW. Li Y, et al. Among authors: liang z. Lancet. 2022 Nov 26;400(10366):1847-1857. doi: 10.1016/S0140-6736(22)01999-7. Epub 2022 Nov 6. Lancet. 2022. PMID: 36351459 Clinical Trial.
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
Han Y, Guo J, Zheng Y, Zang H, Su X, Wang Y, Chen S, Jiang T, Yang P, Chen J, Jiang D, Jing Q, Liang Z, Liu H, Zhao X, Li J, Li Y, Xu B, Stone GW; BRIGHT Investigators. Han Y, et al. Among authors: liang z. JAMA. 2015 Apr 7;313(13):1336-46. doi: 10.1001/jama.2015.2323. JAMA. 2015. PMID: 25775052 Clinical Trial.
[A large-scale, multicenter, retrospective study on efficacy of bivalirudin use during peri-percutaneous coronary intervention period for Chinese patients with coronary heart disease].
Han YL, Chen YD, Jiang TM, Ge JB, Cheng XS, Li JL, Chen YG, Ma YT, Xie Q, Ma LK, Zheng XQ, Yang BS, Chen SL, Wang G, Zhao X, Liu HW, Liang ZY, Liu ML, Wang HY, Li Y. Han YL, et al. Among authors: liang zy. Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Feb;44(2):121-7. doi: 10.3760/cma.j.issn.0253-3758.2016.02.008. Zhonghua Xin Xue Guan Bing Za Zhi. 2016. PMID: 26926504 Chinese.
Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
Wang H, Li Y, Cong H, Ding S, Liu B, Li L, Chen Y, Jia S, Jing Q, Zhao X, Liu H, Liang Z, Li J, Bao D, Han Y. Wang H, et al. Among authors: liang z. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1157-1165. doi: 10.1002/ccd.26804. Epub 2016 Sep 28. Catheter Cardiovasc Interv. 2017. PMID: 27677411 Clinical Trial.
Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.
Wang H, Liang Z, Li Y, Li B, Liu J, Hong X, Lu X, Wu J, Zhao W, Liu Q, An J, Li L, Pu F, Ming Q, Han Y. Wang H, et al. Among authors: liang z. Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12251. Cardiovasc Ther. 2017. PMID: 28083915 Free article.
10,138 results
You have reached the last available page of results. Please see the User Guide for more information.